Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease

Increasing epidemiological evidence highlights the association between systemic insulin resistance and Alzheimer’s disease (AD). As insulin resistance can be caused by high-stress hormone levels and since hypercortisolism appears to be an important risk factor of AD, we aimed to investigate the syst...

Full description

Bibliographic Details
Main Authors: Jhana O. Hendrickx, Sofie De Moudt, Elke Calus, Wim Martinet, Pieter-Jan D. F. Guns, Lynn Roth, Peter P. De Deyn, Debby Van Dam, Guido R. Y. De Meyer
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/13/6656
_version_ 1797529270450388992
author Jhana O. Hendrickx
Sofie De Moudt
Elke Calus
Wim Martinet
Pieter-Jan D. F. Guns
Lynn Roth
Peter P. De Deyn
Debby Van Dam
Guido R. Y. De Meyer
author_facet Jhana O. Hendrickx
Sofie De Moudt
Elke Calus
Wim Martinet
Pieter-Jan D. F. Guns
Lynn Roth
Peter P. De Deyn
Debby Van Dam
Guido R. Y. De Meyer
author_sort Jhana O. Hendrickx
collection DOAJ
description Increasing epidemiological evidence highlights the association between systemic insulin resistance and Alzheimer’s disease (AD). As insulin resistance can be caused by high-stress hormone levels and since hypercortisolism appears to be an important risk factor of AD, we aimed to investigate the systemic insulin functionality and circulating stress hormone levels in a mutant humanized amyloid precursor protein (APP) overexpressing (hAPP23+/−) AD mouse model. Memory and spatial learning of male hAPP23+/− and C57BL/6 (wild type, WT) mice were assessed by a Morris Water Maze (MWM) test at the age of 4 and 12 months. The systemic metabolism was examined by intraperitoneal glucose and insulin tolerance tests (GTT, ITT). Insulin and corticosterone levels were determined in serum. In the hippocampus, parietal and occipital cortex of hAPP23+/− brains, amyloid-beta (Aβ) deposits were present at 12 months of age. MWM demonstrated a cognitive decline in hAPP23+/− mice at 12 but not at 4 months, evidenced by increasing total path lengths and deteriorating probe trials compared to WT mice. hAPP23+/− animals presented increased serum corticosterone levels compared to WT mice at both 4 and 12 months. hAPP23+/− mice exhibited peripheral insulin resistance compared to WT mice at 4 months, which stabilized at 12 months of age. Serum insulin levels were similar between genotypes at 4 months of age but were significantly higher in hAPP23+/− mice at 12 months of age. Peripheral glucose homeostasis remained unchanged. These results indicate that peripheral insulin resistance combined with elevated circulating stress hormone levels could be potential biomarkers of the pre-symptomatic phase of AD.
first_indexed 2024-03-10T10:11:23Z
format Article
id doaj.art-1d85c304985641a5b8dc26727b5e1314
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:11:23Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1d85c304985641a5b8dc26727b5e13142023-11-22T01:09:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-012213665610.3390/ijms22136656Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s DiseaseJhana O. Hendrickx0Sofie De Moudt1Elke Calus2Wim Martinet3Pieter-Jan D. F. Guns4Lynn Roth5Peter P. De Deyn6Debby Van Dam7Guido R. Y. De Meyer8Laboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Neurochemistry and Behaviour, Institute Born-Bunge, Department of Biomedical Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Neurochemistry and Behaviour, Institute Born-Bunge, Department of Biomedical Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Neurochemistry and Behaviour, Institute Born-Bunge, Department of Biomedical Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumLaboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, Universiteitsplein 1, University of Antwerp, 2610 Wilrijk, Antwerp, BelgiumIncreasing epidemiological evidence highlights the association between systemic insulin resistance and Alzheimer’s disease (AD). As insulin resistance can be caused by high-stress hormone levels and since hypercortisolism appears to be an important risk factor of AD, we aimed to investigate the systemic insulin functionality and circulating stress hormone levels in a mutant humanized amyloid precursor protein (APP) overexpressing (hAPP23+/−) AD mouse model. Memory and spatial learning of male hAPP23+/− and C57BL/6 (wild type, WT) mice were assessed by a Morris Water Maze (MWM) test at the age of 4 and 12 months. The systemic metabolism was examined by intraperitoneal glucose and insulin tolerance tests (GTT, ITT). Insulin and corticosterone levels were determined in serum. In the hippocampus, parietal and occipital cortex of hAPP23+/− brains, amyloid-beta (Aβ) deposits were present at 12 months of age. MWM demonstrated a cognitive decline in hAPP23+/− mice at 12 but not at 4 months, evidenced by increasing total path lengths and deteriorating probe trials compared to WT mice. hAPP23+/− animals presented increased serum corticosterone levels compared to WT mice at both 4 and 12 months. hAPP23+/− mice exhibited peripheral insulin resistance compared to WT mice at 4 months, which stabilized at 12 months of age. Serum insulin levels were similar between genotypes at 4 months of age but were significantly higher in hAPP23+/− mice at 12 months of age. Peripheral glucose homeostasis remained unchanged. These results indicate that peripheral insulin resistance combined with elevated circulating stress hormone levels could be potential biomarkers of the pre-symptomatic phase of AD.https://www.mdpi.com/1422-0067/22/13/6656hypercortisolisminsulin resistancehypermetabolismcognitive declineAlzheimer’s disease
spellingShingle Jhana O. Hendrickx
Sofie De Moudt
Elke Calus
Wim Martinet
Pieter-Jan D. F. Guns
Lynn Roth
Peter P. De Deyn
Debby Van Dam
Guido R. Y. De Meyer
Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
International Journal of Molecular Sciences
hypercortisolism
insulin resistance
hypermetabolism
cognitive decline
Alzheimer’s disease
title Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
title_full Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
title_fullStr Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
title_full_unstemmed Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
title_short Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
title_sort serum corticosterone and insulin resistance as early biomarkers in the happ23 overexpressing mouse model of alzheimer s disease
topic hypercortisolism
insulin resistance
hypermetabolism
cognitive decline
Alzheimer’s disease
url https://www.mdpi.com/1422-0067/22/13/6656
work_keys_str_mv AT jhanaohendrickx serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT sofiedemoudt serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT elkecalus serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT wimmartinet serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT pieterjandfguns serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT lynnroth serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT peterpdedeyn serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT debbyvandam serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease
AT guidorydemeyer serumcorticosteroneandinsulinresistanceasearlybiomarkersinthehapp23overexpressingmousemodelofalzheimersdisease